Global Healthcare Licensing: Monthly Report

  • ID: 4451064
  • Report
  • 165 pages
  • FinGlobe, Inc
1 of 3

As more and more progress in the life sciences sector occurs by a combination of different technologies, the growth of agreements implying activities of research and development, co-promoting and co-marketing has been strong. These licensing arrangements influence the healthcare markets and are therefore an important factor for consideration for companies for their healthcare investments. This monthly report brings at one place all such licensing deals and negotiations that takes place among global healthcare companies every month.

Key Features:

  • Global healthcare licensing transactions of each month at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing regulatory news updates

The Report is useful to:

  • Global healthcare companies planning to introduce products in other countries
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals
Note: Product cover images may vary from those shown
2 of 3


Section 1: Summary of global healthcare inventions licensed during previous month

1.1 Healthcare sub-sector with most licensing deals
1.2 Countries with most licensing deals
1.3 Market capitalization groups with most licensing deals
1.4 Medicine categories (cure groups) most active in licensing deals
1.5 Licensing payment arrangements most followed
1.6 Worldwide licensing vs domestic licensing
1.7 R&D licensing vs commercialization licensing

Section 2: Global healthcare inventions licensed during previous month

2.1 By region and company name
2.2 By sub-industry and company name
2.3 By market capitalization group and company name
2.4 By terms of payment and company name
2.5 By medical groups and company name

Section 3: Global healthcare invention licenses discontinued during previous month


Appendix 1: List of new companies/institutes involved in global healthcare invention licensing during previous month: By region, country and name

Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown